Member Info for Laura2022

Our client is CruK

dose and dose range for an upcoming First in Human Study.

 

Dr Peter Sargent, CEO, commented: "We are delighted to have been awarded this new contract with one of our existing clients. This contract reflects the impact of the services we provide and our continued relationship with Cancer Research UK".

 

Cruk are the intermediary

Best wishes AVCT as we're both trying to combat this awful diseases

That's because the contract was 2 weeks ago

I like your comedy value and penchant for porky and nick

I don't but thanks

Pyc got the contract on 17th Oct

Sky and CRUK break the news this morning

Pyc responded 3hrs ago with

Physiomics plc

1,696 followers

3h  Edited

We’re thrilled to continue our partnership with Cancer Research UK (CRUK) on an exciting new project! 🎉 We’ll be working on developing a PK/PD model to simulate the exposure-response relationship for a novel oncology therapy. This work will help guide the starting dose and dose range for an upcoming First-In-Human study.

Yes Icecool

PYC do the precision dosing /modelling

Hence why they've just posted on LinkedIn (PYC)

It was indeed Pyc

Cannot buy £1000

Can't get any buys at 0.65p...been like this for an hour now

14.5/15 now

I bought primarily as cash pile worth more than the company at 9p

That would be amazing

Large buys today

Oxmil

Pyc do.both

See the presentation

Clarets

The rns was last week , we have commented on the breaking news via LinkedIn as we can't officially break the news as a3rd party

GB

It was the P company!!.. see there now re: brain camcer

"Personalised precision medicine " which is PYC

This targeted treatment approach underpins the vision of the new Cambridge Cancer Research Hospital, a partnership between Addenbrooke's Hospital, the University of Cambridge and the Cancer Research UK Cambridge Centre.

By bringing world-leading scientists and clinical expertise together, the new hospital will deliver breakthroughs and innovations to change the way we detect and treat cancer, to diagnose the disease at a much earlier stage and deliver personalised, precision medicine

PYC always do linkdins once news is made public

This is PYC saying "we are involved "

Massive boost

Exactly 99

And $1.5mln+ cost cuts give them time to seek options as shown in RNS

GB

Confirmation...It WAS our company for the brain cancers

drug